Omeros announces results for narsoplimab expanded access program
Omeros (OMER) announced statistical analysis results related to the expanded access program for narsoplimab, Omeros’ ...
The American Journal of Managed Care14h
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem ...
labiotech17h
The future of organ transplants: Xenotransplantation, 3D bioprinting and stem cells
Explore the future of organ transplants and how biotech innovations like 3D bioprinting and stem cells can solve the organ ...
Healio21h
BLOG: Optimizing donor selection in aplastic anemia — evolving trends in transplantation
Aplastic anemia is a bone marrow failure process that presents with pancytopenia and bone marrow hypoplasia/aplasia.It ...
Targeted Oncology18h
CARTITUDE-4 Highlights: Cilta-Cel vs Standard of Care in R/R MM
Panelists discuss how CARTITUDE-4 demonstrated superior progression-free survival and overall response rates with ...
Frontiers15h
The Impact of Biological Sex on Transplantation: From Bench to Bedside
To date, both basic and clinical research have predominantly focused on male patients, animals, and cells, often overlooking the critical role of biological ...
Nature23h
About the Editors
Like the other Nature titles, Nature Cell Biology has no external editorial board. Instead, all editorial decisions are made by a dedicated team of professional editors, with relevant research and ...